Cell & Gene Therapy Manufacturing Services Market Size Worth US$ 70.7 Billion by 2032, Amid Rising Clinical Trials | Research by SNS Insider
17 sept. 2024 08h45 HE
|
SNS Insider pvt ltd
Pune, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Cell & Gene Therapy Manufacturing Services Market Analysis: “The Cell & Gene Therapy Manufacturing Services Market is experiencing rapid growth,...
Abata Therapeutics Appoints Joanne Beck, Ph.D., as Chief Technical Officer
16 sept. 2024 07h00 HE
|
Abata
Abata Therapeutics Appoints Joanne Beck, Ph.D., as Chief Technical Officer
Cell Therapy Manufacturing Market Historical Trends (2022-2023) and Forecasted Estimates (2024-2035)
16 sept. 2024 05h12 HE
|
Research and Markets
Dublin, Sept. 16, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapy Manufacturing Market (6th Edition): Industry Trends and Global Forecasts to 2035 - Distribution by Type of Cell Therapy, Source of Cells,...
NMDP℠ Organizes Nationwide Fundraisers to Propel Research, Aid Patients with Blood Cancer and Diseases
13 sept. 2024 09h00 HE
|
NMDP
NMDP, a global leader in cell therapy, will host its first-ever community event series, NMDP: Unite to help find cures for blood cancers and diseases.
Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference
12 sept. 2024 16h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024
09 sept. 2024 16h05 HE
|
Avid Bioservices, Inc
-- Recorded First Quarter Revenue of $40.2 Million -- -- Signed $66 Million in Net New Business, Resulting in Backlog of $219 Million -- -- Maintained FY2025 Revenue Guidance of Between $160...
Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024
06 sept. 2024 07h00 HE
|
https://immatics.com/
Houston, Texas and Tuebingen, Germany, September 06, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the discovery and...
Laverock Therapeutics announces forthcoming investor, scientific and partnering conference schedule
05 sept. 2024 04h00 HE
|
Laverock Therapeutics
STEVENAGE, United Kingdom, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced...
Cell Therapy Market Size to Hit USD 28.98 Billion by 2032, Driven by Advances in Personalized Medicine and Stem Cell Applications | SNS Insider
04 sept. 2024 09h00 HE
|
SNS Insider pvt ltd
Pune, Sept. 04, 2024 (GLOBE NEWSWIRE) -- “According to SNS Insider, The Cell Therapy Market, valued at USD 4.65 billion in 2023 and is projected to reach USD 28.98 billion by 2032, driven by a...
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024
03 sept. 2024 16h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...